These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11152496)

  • 21. Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees.
    Kowalski H; Erickson AL; Cooper S; Domena JD; Parham P; Walker CM
    J Exp Med; 1996 Apr; 183(4):1761-75. PubMed ID: 8666933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.
    Rehermann B; Chang KM; McHutchinson J; Kokka R; Houghton M; Rice CM; Chisari FV
    J Virol; 1996 Oct; 70(10):7092-102. PubMed ID: 8794355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
    AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
    Lauer GM; Ouchi K; Chung RT; Nguyen TN; Day CL; Purkis DR; Reiser M; Kim AY; Lucas M; Klenerman P; Walker BD
    J Virol; 2002 Jun; 76(12):6104-13. PubMed ID: 12021343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.
    Nelson DR; Marousis CG; Ohno T; Davis GL; Lau JY
    Hepatology; 1998 Jul; 28(1):225-30. PubMed ID: 9657116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F; Eckels DD
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
    Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
    J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
    Kurokohchi K; Arima K; Nishioka M
    J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.
    Fang SH; Chiang BL; Wu MH; Iba H; Lai MY; Yang PM; Chen DS; Hwang LH
    J Clin Microbiol; 2001 Nov; 39(11):3895-901. PubMed ID: 11682504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of successful immune responses in persons infected with hepatitis C virus.
    Lechner F; Wong DK; Dunbar PR; Chapman R; Chung RT; Dohrenwend P; Robbins G; Phillips R; Klenerman P; Walker BD
    J Exp Med; 2000 May; 191(9):1499-512. PubMed ID: 10790425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.
    Cucchiarini M; Kammer AR; Grabscheid B; Diepolder HM; Gerlach TJ; Grüner N; Santantonio T; Reichen J; Pape GR; Cerny A
    Cell Immunol; 2000 Aug; 203(2):111-23. PubMed ID: 11006009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
    Koziel MJ; Dudley D; Afdhal N; Grakoui A; Rice CM; Choo QL; Houghton M; Walker BD
    J Clin Invest; 1995 Nov; 96(5):2311-21. PubMed ID: 7593618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.
    Erickson AL; Kimura Y; Igarashi S; Eichelberger J; Houghton M; Sidney J; McKinney D; Sette A; Hughes AL; Walker CM
    Immunity; 2001 Dec; 15(6):883-95. PubMed ID: 11754811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells.
    Ito A; Kanto T; Kuzushita N; Tatsumi T; Sugimoto Y; Miyagi T; Takehara T; Katayama K; Mochizuki K; Hiramatsu N; Kasahara A; Yoshiya I; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2001 Mar; 16(3):309-16. PubMed ID: 11339423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.